PM

Pavan Mukesh Ramteke

Active Director Director DIN 10761927
DIN 10761927 First appointment Aug 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value •••• Premium profile

About Pavan Mukesh Ramteke

Data last updated:

Pavan Mukesh Ramteke is a Director at Aero Hospital Private Limited (since 2024). Aero Hospital Private Limited reported revenue of ₹15.6 Lakh (FY 2025).

DIN 10761927
Primary Designation Director
First Appointment 30 Aug 2024
Oldest Company Age 2 yrs
Largest company Aero Hospital Private Limited · ₹15.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aero Hospital Private Limited U86100MH2024PTC431574
Director30 Aug 20242024₹15.6 Lakh (FY 2025)Active

Board colleagues of Pavan Mukesh Ramteke

NameDINCompanyDesignation
Anil Shriram Raut10761928Aero Hospital Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aero Hospital Private Limited
Premium access

Shareholding and investment profile for Pavan Mukesh Ramteke

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pavan Mukesh Ramteke

Pavan Mukesh Ramteke currently holds 1 directorship: Aero Hospital Private Limited (Director, since 30 Aug 2024, revenue ₹15.6 Lakh (FY 2025)).

Pavan Mukesh Ramteke was first appointed on 30 Aug 2024 as Director at Aero Hospital Private Limited.

The current boards of Pavan Mukesh Ramteke's companies include Anil Shriram Raut (Aero Hospital Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available